RVNCRevance Therapeutics Inc

$0.00
$0.00
(0.00%)
Today
Updated:
Reported EarningsNov 7
Mkt Cap$381.02M
Vol4.12M
53

Neutral Sentiment

How do you feel about RVNC?

About

Revance Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications. The firm focuses on production of daxibotulinumtoxinA, a botulinum toxin, for aesthetic and therapeutic indications including facial wrinkles and muscle movement disorders. The company was founded by Jacob M. Waugh and L. Daniel Browne on August 10, 1999 and is headquartered in Nashville, TN.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Revance Therapeutics Inc?
What is the 52-week high for Revance Therapeutics Inc?
What is the 52-week low for Revance Therapeutics Inc?
What is Revance Therapeutics Inc stock price today?
What was Revance Therapeutics Inc stock price yesterday?
What is the PE ratio of Revance Therapeutics Inc?
What is the Price-to-Book ratio of Revance Therapeutics Inc?
What is the 50-day moving average of Revance Therapeutics Inc?

Advertisement|Remove ads.